General discussion, page-20217

First 20217 Last

Share
Profile

Follow
Breakingsystem

415 Posts.

164

13/09/24

12:58

Post #: 75661959
Share

Originally posted by UnclePanda: ↑

it’s clear why management don’t respond to shareholders.

they don’t neeed us anymore - they got all their shares approved by us before the NASDAQ and are sitting happy, waiting for results. they are likely thinking that results will drive the share price - not shareholder sentiment. But the last time, it was sentiment which drove the share price to 70 cents. Hotcopper was really different back then - a positive place.

now the company is fundamentally better and about to release phase 2b results - management likely think this will be enough to show the market and turn around the share price. I hope it is. But unfortunately if shareholder sentiment isn’t there (which it isn’t as confidence is at all time lows), the news event will prob turn into another pump and dump.

we are written off by the US market as just another unicorn pie in the sky Penny dreadful punt. If we weren’t, we certainly wouldn’t be capped at $27M or so before a major news event.

this is prob because there is another drug approved by the FDA to treat moderate sleep apnoea in November last year - Zepbound (terzepatide) developed by major pharma Eli Lilly. They have asked the FDA to expand the approval to severe cases- not only moderate. A decision is due by the end of year.

very unfortunate times for ASX shareholders

Expand

Zepbound is a competitor to ozempic and aimed at weight loss. Losing weight can definitely improve sleep apnea symptoms but it's certainly not a direct competitor to 42x.
imho, retail holders are meaningless and institutional investments are just around the corner. too many catalysts around the corner to keep this beast tamed, and I doubt we will see dumps after pumps going forward if results are as expected. Then again, this is incannex and we never know. GL to all involved

IHL Price at posting: 4.1¢ Sentiment: Hold Disclosure: Held
10 Upvote

0 Great analysis

Reply

Top Stories

MMI

Metro Mining inks bauxite offtake contracts into 2026 with Chinese m

HotCopper Highlights: Your most watched and most discussed stocks this week

Trump is President Again: What Does This Mean for Crypto?

Trump Victory Sends Bitcoin Surging Above $75K – Is $100K Next?

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

FG1

Flynn Gold reaches milestone exploration target for Golden Ridge

UBI

Universal Biosensors flat despite fresh deal with US medical product distributor

Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive

IMU

Imugene kicks off Australian trial for blood cancer treatment

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited